BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27473338)

  • 21. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
    Kovalova N; Manzan M; Crawford R; Kaminski N
    Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
    Wood SC; Jeong HG; Morris DL; Holsapple MP
    Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD.
    Wood SC; Holsapple MP
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):308-13. PubMed ID: 8212013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
    North CM; Crawford RB; Lu H; Kaminski NE
    Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
    Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
    BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5
    Blevins LK; Zhou J; Crawford RB; Kaminski NE
    Front Immunol; 2021; 12():635748. PubMed ID: 33936048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line.
    Bhakta-Yadav MS; Burra K; Alhamdan N; Allex-Buckner CP; Sulentic CEW
    Toxicol Sci; 2024 May; 199(2):276-288. PubMed ID: 38526216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Neubert R; Jacob-Müller U; Stahlmann R; Helge H; Neubert D
    Arch Toxicol; 1990; 64(5):345-59. PubMed ID: 2403285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2,3,7,8-tetrachlorodibenzo-p-dioxin does not directly alter the phenotype of maturing B cells in a murine coculture system.
    Wyman A; Lavin AL; Wilding GE; Gasiewicz TA
    Toxicol Appl Pharmacol; 2002 May; 180(3):164-77. PubMed ID: 12009856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Doi H; Baba T; Tohyama C; Nohara K
    Chemosphere; 2003 Jul; 52(4):655-62. PubMed ID: 12738279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
    Salisbury RL; Sulentic CE
    Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,3,7,8-Tetrachlorodibenzo-p-dioxin elicits aryl hydrocarbon receptor-mediated apoptosis in the avian DT40 pre-B-cell line through activation of caspases 9 and 3.
    Puebla-Osorio N; Ramos KS; Falahatpisheh MH; Smith R; Berghman LR
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Aug; 138(4):461-8. PubMed ID: 15536054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
    Fan F; Wierda D; Rozman KK
    Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
    Snyder NK; Kramer CM; Dooley RK; Holsapple MP
    Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte.
    Dooley RK; Holsapple MP
    Immunopharmacology; 1988; 16(3):167-80. PubMed ID: 3267010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.